ImageneBio Inc (IMA) Stock Price, Quote, News & History

IMANASDAQ
$5.51
-0.10-1.78%
At close: Aug 20, 5:00 PM EST
$5.54
-0.0706-1.26%
Pre-Market: 7:56 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-52.59M
Investing Cash Flow (TTM)
-6.60M
Financing Cash Flow (TTM)
147.23M
Free Cash Flow (TTM)
-52.59M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
88.04M

Analyst Trends and Forecast

1
May
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
2.9
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$71.58M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.44
Earnings Yield % (TTM)
-85.66%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$12.52

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$94.68M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$5.51
Volume / Avg.
25.00 / 12.30K
Day Range
- - -
52 Wk Range
3.94 - 14.34
Market Cap
$62.88M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
3.44%
Days to Cover
29.6

About

Sector
Health Care
Industry
Pharmaceuticals
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that b...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy ImageneBio (IMA) stock?

A

You can purchase shares of ImageneBio (NASDAQ:IMA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ImageneBio (IMA) competitors?

Q

What is the forecast, or price target, for ImageneBio (IMA) stock?

A

ImageneBio has a consensus price target of $20.00.

Q

What is the current price for ImageneBio (IMA)?

A

The stock price for ImageneBio (NASDAQ: IMA) is $5.5394 last updated August 21, 2026 at 4:54 PM EDT.

Q

Does ImageneBio (IMA) pay a dividend?

A

There are no upcoming dividends for ImageneBio.

Q

When is ImageneBio (NASDAQ:IMA) reporting earnings?

A

ImageneBio does not have any upcoming earnings scheduled.

Q

Is ImageneBio (IMA) going to split?

A

There is no upcoming split for ImageneBio.

Q

What sector and industry does ImageneBio (IMA) operate in?

A

ImageneBio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.